Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies

Kajsa P. Kanebratt and Tommy B. Andersson
Drug Metabolism and Disposition July 2008, 36 (7) 1444-1452; DOI: https://doi.org/10.1124/dmd.107.020016
Kajsa P. Kanebratt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tommy B. Andersson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 36 no. 7 1444-1452
DOI 
https://doi.org/10.1124/dmd.107.020016
PubMed 
18385292

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received December 6, 2007
  • Accepted April 1, 2008
  • Published online June 19, 2008.

Article Versions

  • Earlier version (April 2, 2008 - 08:09).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kajsa P. Kanebratt and
  2. Tommy B. Andersson
  1. Development DMPK and Bioanalysis, AstraZeneca R&D, Mölndal, Sweden (K.P.K., T.B.A.); Division of Clinical Pharmacology, Department of Laboratory Medicine at Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden (K.P.K.); and Section of Pharmacogenetics, Department of Physiology and Pharmacology at Karolinska Institutet, Stockholm, Sweden (T.B.A.)
  1. Address correspondence to:
    Tommy B. Andersson, Development DMPK and Bioanalysis, AstraZeneca R&D Mölndal, S-431 83 Mölndal, Sweden. E-mail: tommy.b.andersson{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to May 2023

AbstractFullPdf
Aug 201777526
Sep 2017106521
Oct 2017137649
Nov 2017911546
Dec 2017126534
Jan 2018129248
Feb 201839569
Mar 201839060
Apr 201819259
May 201809766
Jun 201829357
Jul 2018110669
Aug 201809251
Sep 201808535
Oct 201809261
Nov 2018010759
Dec 2018563728
Jan 20191002232
Feb 2019702416
Mar 2019115915
Apr 20191202129
May 2019951419
Jun 20191211723
Jul 20191441428
Aug 20191081618
Oct 20191401319
Nov 20191021916
Dec 20191211921
Jan 20201021316
Feb 2020811417
Mar 2020761618
May 202066110
Jun 2020741714
Jul 2020741222
Aug 202084312
Sep 2020701618
Oct 202084919
Nov 20208528
Dec 202081819
Jan 2021823719
Feb 20211443521
Mar 2021642310
Apr 2021781725
May 2021931211
Jun 2021671910
Jul 2021411413
Aug 202133168
Sep 2021772013
Oct 2021107117
Nov 202194138
Dec 202152915
Jan 2022621113
Feb 20228914
Mar 202259107
Apr 202267157
May 202211176
Jun 20225986
Jul 2022641218
Aug 20225479
Sep 20227484
Oct 2022952323
Nov 2022751111
Dec 2022861110
Jan 20231161212
Feb 202385710
Mar 202311998
Apr 2023721213
May 2023761917

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (7)
Drug Metabolism and Disposition
Vol. 36, Issue 7
1 Jul 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies

Kajsa P. Kanebratt and Tommy B. Andersson
Drug Metabolism and Disposition July 1, 2008, 36 (7) 1444-1452; DOI: https://doi.org/10.1124/dmd.107.020016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies

Kajsa P. Kanebratt and Tommy B. Andersson
Drug Metabolism and Disposition July 1, 2008, 36 (7) 1444-1452; DOI: https://doi.org/10.1124/dmd.107.020016
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Adipocyte PXR does not play an essential role in obesity.
  • CYP3A-mediated oxidation of DABE and BIBR0951
  • Biodistribution of Lipid in Rats
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics